PDF program

10:00-11:00   Registration
11:00-12:30   Session I
Chair: Christoph Schankin, Bern
11:00-11:05   Welcome
Christoph Schankin, Bern | Andreas Kleinschmidt, Geneva
11:05-11:50   Keynote: Chronic tension-type headache
Lars Bendtsen, Glostrup, DK
11:50-12:10   Chronic secondary headaches not to miss
Athina Papadopoulou, Basel
12:10-12:30   Medication overuse: new paradigm? 
Franz Riederer, Bern
12:30-13:30   Lunch Break in the Industry Exhibition
13:30-14:30   Industry Flash Session
What's New?
Moderator: Andreas R. Gantenbein, Bülach
13:30-13:45   ELI LILLY (SUISSE) SA
Galcanezumab with traditional oral migraine preventives: real-world effectiveness
Franz Riederer, Bern
13:45-14:00   TEVA PHARMA AG
Real World Update Fremanezumab
Alexander Maurer, Bern
14:00-14:15   ABBVIE AG
Botulinum Toxin in a nutshell: Answers to your key clinical questions
Constanze Kämpfer, Geneva | Franz Riederer, Bern
14:15-14:30   LUNDBECK (SCHWEIZ) AG
Evidence meets Experience - Expanding treatment options with an IV aCGRP
Anamaria Ungureanu, Zurich
14:30-15:00   Coffee Break in the Industry Exhibition
15:00-16:30   Session II
Chair: Chiara Zecca, Lugano
15:00-15:05   Welcome
Chiara Zecca, Lugano
15:05-15:50   Keynote: In- or outpatient; invasive or non-invasive? How to treat refractory chronic primary headaches?
Gisela M. Terwindt, Leiden, NL
15:50-16:10   Multimodal therapy of chronic headaches
Peter Sandor, Baden
16:10-16:30   SHS Hansruedi Isler Research Fellowship 2023
Moderation: Andreas Kleinschmidt, Geneva

16:10-16:15 Award Ceremony
16:15-16:25 Presentation of recipient
16:25-16:30 Q & A
16:30-17:00   Apéro in the Industry Exhibition
17:00-18:00   SHS General Assembly 2023


Status: October 17, 2023